Mersana Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO

Martin H. Huber

CEOMartin H. Huber

Employees

102

Employees102

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

102

Employees102

MRSN Key Statistics

Market cap

45.61M

Market cap45.61M

Price-Earnings ratio

-0.64

Price-Earnings ratio-0.64

Dividend yield

—

Dividend yield—

Average volume

2.60M

Average volume2.60M

High today

$0.3798

High today$0.3798

Low today

$0.35

Low today$0.35

Open price

$0.37

Open price$0.37

Volume

1.69M

Volume1.69M

52 Week high

$3.63

52 Week high$3.63

52 Week low

$0.2589

52 Week low$0.2589

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

11.1%

Sell